DHR
Danaher CorporationPharmaceuticals, Biotechnology & Life Sciences
- Rank · 2026
- #325
- Final score
- 57.22
- Years on list
- 7
↗ Climbed 44 since 2020
Compare · Up to four Russell 1000 companies
Select two, three, or four Russell 1000 companies to compare their overall rank, year-by-year trajectory, and scores down to the category level.
Figure 01 · Side-by-side summary
Pharmaceuticals, Biotechnology & Life Sciences
↗ Climbed 44 since 2020
Pharmaceuticals, Biotechnology & Life Sciences
↘ Down 7 since 2020
Pharmaceuticals, Biotechnology & Life Sciences
↗ Climbed 261 since 2020
Figure 02 · Rank trajectory
Lower is better. The y-axis is inverted so a rising line means an improving rank. Missing years mean the company didn't make the top 100 that year.
Figure 03 · Pillar profile · 2026
Latest-year ESG pillar scores, 0–100. The shaded bar shows relative strength across the selected companies for each pillar.
| Pillar | DHR | LLY | ZTS |
|---|---|---|---|
| Climate Change | 70.2 | 63.9 | 63.7 |
| Employee Relations | 49.4 | 59.4 | 51.8 |
| Environment | 47.6 | 63.1 | 57.1 |
| Stakeholders & Society | 64.7 | 56.4 | 50.6 |
| Human Rights | 56.1 | 36.7 | 45.6 |
| Governance | 51.0 | 53.1 | 68.2 |
| Performance Rating | 62.0 | 66.7 | 51.3 |